Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 10, 2023

Details for New Drug Application (NDA): 016151

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 016151 describes UREX, which is a drug marketed by Alvogen and is included in one NDA. It is available from one supplier. Additional details are available on the UREX profile page.

The generic ingredient in UREX is methenamine hippurate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
Summary for 016151
Ingredient:methenamine hippurate
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016151
Suppliers and Packaging for NDA: 016151
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
UREX methenamine hippurate TABLET;ORAL 016151 NDA Alvogen Inc. 47781-577 47781-577-01 100 TABLET in 1 BOTTLE (47781-577-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.